Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Nona Biosciences Enters Strategic Collaboration with OverT Bio to Advance Next-Generation Cell Therapies for Solid Tumors 2024-10-09 20:00
Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding 2024-10-09 15:23
The CDE has Granted Breakthrough Therapy Designation to LBL-024, a Bispecific Antibody that Targets PD-L1 and 4-1BB, Developed by Leads Biolabs, for the Treatment of Extrapulmonary Neuroendocrine Carcinoma. 2024-10-09 13:32
Joint Venture Company Established for Incubation of Early Drug Discovery Programs; Investment from Takeda, Astellas and Sumitomo Mitsui Banking 2024-10-09 10:00
Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions 2024-10-08 20:00
MicuRx Pharmaceuticals Announces Promising Results from MRX-5 Study for Treating Mycobacterium abscessus Infections 2024-10-08 13:38
Sciwind Biosciences Announces Oral Presentation on Oral GLP-2 Research Progress at the 32nd United European Gastroenterology Week (UEG Week 2024) 2024-10-08 10:00
MediLink Announces Global Clinical Trial Collaboration and Supply Agreement on YL201 Combination Therapy 2024-10-08 08:00
The Exosome Production Method Patent by Panacell Biotech Registered as Original Technology 2024-10-03 20:00
South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika 2024-10-02 20:00
PeptiGrowth Inc. is Launching a Novel Synthetic FGF2 Alternative Peptide (FGFR1c Agonist) 2024-10-01 21:00
NUS researchers develop revolutionary technology to unravel complex protein interactions that could transform cancer diagnostics 2024-09-30 15:51
Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of Severe Hypertriglyceridemia 2024-09-30 15:00
IASO Bio Scientist and Leading Chinese Physicians in Onco-Hematology Visit Hematology Center at the State University of Campinas, Brazil, to Explore Cooperation in Cancer Treatment 2024-09-30 13:48
Akeso's Cadonilimab Receives Second Indication Approval from NMPA for First-Line Treatment of Gastric/GEJ Cancer in All-Comers Population 2024-09-30 13:42
Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor's Portfolio of next-generation CDK inhibitors for the Treatment of Breast Cancer 2024-09-30 13:00
SeromYx Systems and ACROBiosystems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies 2024-09-29 21:00
IASO Bio Presented Comparative Clinical Outcomes on the Optimal Lymphodepletion Prior to Infution of Equecabtagene Autoleucel（FucasoTM）in Patients with Relapsed Refractory Multiple Myeloma at 2024 IMS Annual Meeting 2024-09-29 21:00
New Beginnings, New Journey | Sanyou Opening of New 10,000-sqm Facility, Ushering in a New Era of Innovation for Bio Drugs 2024-09-28 20:00
IASO Bio Presented the Outcomes of Relapsed/Refractory Multiple Myeloma (R/RMM) Patients with Renal Impairment Treated with Equecabtagene Autoleucel (Fucaso™) at 2024 IMS Annual Meeting 2024-09-27 15:41
1 9 10 11 12 13 227